|
Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status
|
03 June 2026 |
|
Chronic lymphocytic leukemia: long-lasting remission with combination of cyclophosphamide, somatostatin, bromocriptine, retinoids, melatonin, and ACTH
|
02 June 2026 |
|
Complete objective response to biological therapy of plurifocal breast carcinoma
|
29 May 2026 |
|
Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
|
02 January 2026 |
|
Melatonin protects rat liver against irradiation-induced oxidative injury
|
12 December 2025 |
|
Melatonin: new places in therapy
|
14 October 2025 |
|
MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells
|
14 October 2025 |
|
Different responsiveness of central nervous system tissues to oxidative conditions and to the antioxidant effect of melatonin
|
06 October 2025 |
|
Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines
|
06 October 2025 |
|
Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger
|
29 July 2025 |